Bristol Myers Climbs, Adobe Drops, Salesforce Gains as BofA Raises to Buy on AI Strategy | Stock...
Community Score: 50% | 15 views | 3d
0 community ratings: null thumbs up, null thumbs down
On this episode of Stock Movers: - Bristol Myers (BMY) shares climb. Bristol Myers Squibb Co.’s experimental drugs for treating a rare endocrine cancer and a deadly form of lung disease showed promise in late-stage studies, a potential boon for the pharmaceutical company’s new product pipeline. Wall Street has been eagerly anticipating both results, as the drugs use novel approaches for hard-to-treat conditions that impair patients’ quality of life and are eventually fatal. - Adobe (ADBE) shares drop. Wells Fargo Securities downgraded the maker of software for creative professionals by two notches, to underweight from overweight. - Salesforce (CRM) shares gain. BofA Global Research raised the recommendation on the software company to buy from underperform, pointing to tailwinds from AI adoption. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analy
Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast
More from Bloomberg Podcasts
- Follow the Money All the Way to Carney's Canada — Score: 50%
- Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
- Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
- We hear you! | Bloomberg Hot Pursuit! — Score: 50%
- Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
- Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%